CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 56 enrolled
Drug / intervention
liraglutide +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02527200
NCT02527200Phase 3Completed
CompareCT.gov

Effect of Liraglutide for Weight Management in Paediatric Subjects With Prader-Willi Syndrome.

Novo Nordisk A/S·interventional·Posted Aug 18, 2015·Updated Jul 6, 2023

In Brief

A Phase 3 clinical trial evaluating liraglutide and placebo for Metabolism and Nutrition Disorder and Obesity. Completed, enrolled 56 participants across 32 sites in 8 countries.

Detailed Summary

This trial is conducted globally. The aim of this trial is to investigate the effect of liraglutide for weight management in paediatric subjects with Prader-Willi Syndrome.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMetabolism and Nutrition Disorder, Obesity
CountriesAustralia, Canada, France, Italy, Netherlands, New Zealand, Turkey (Türkiye), United States
Collaborators--

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedAug 18, 2015
Enrollment StartNov 9, 2015
Primary CompletionNov 4, 2020
Study CompletionNov 19, 2020
TodayJul 2, 2026
Enrollment to primary: 5.0 yearsPosted 10.9 years ago

Interventions

liraglutidedrug

Injected s.c./ subcutaneously (under the skin) This trial consists of a part A and a part B. Part A of the trial is conducted in obese adolescents with PWS. Part B of the trial is conducted in obese children with PWS. Entry into part A and part B of the trial will be sequential.

placebodrug

Injected s.c./ subcutaneously (under the skin) This trial consists of a part A and a part B. Part A of the trial is conducted in obese adolescents with PWS. Part B of the trial is conducted in obese children with PWS. Entry into part A and part B of the trial will be sequential.